Blockade of tumour necrosis factor-α in rheumatoid arthritis:: effects on components of rheumatoid cachexia

被引:113
作者
Metsios, G. S.
Stavropoulos-Kalinoglou, A.
Douglas, K. M. J.
Koutedakis, Y.
Nevill, A. M.
Panoulas, V. F.
Kita, M.
Kitas, G. D.
机构
[1] Russells Hall Hosp, Dudley Grp Hosp NHS Trust, Dept Rheumatol, Dudley, W Midlands, England
[2] Wolverhampton Univ, Sch Sport Performing Arts & Leisure, Walsall, W Midlands, England
[3] Ctr Res & Technol, Res Inst Phys Performance & Rehabil, Thessaly, Trikala, Greece
关键词
anti-TNF-alpha; resting energy expenditure; metabolism; rheumatoid cachexia; rheumatoid arthritis; adipose tissue; cytokines; inflammation; muscle; biological therapy;
D O I
10.1093/rheumatology/kem291
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives. Rheumatoid arthritis (RA) is accompanied by increased resting energy expenditure (REE) and decreased fat-free mass (FFM). This is referred to as rheumatoid cachexia and is attributed to high levels of tumour necrosis factor-alpha(TNF-alpha). This study aimed to investigate the effects of anti-TNF-alpha therapy on REE, body composition, physical activity and protein intake in RA patients. Methods. Twenty RA patients [50% female; age: (mean +/- s.d.) 61.1 +/- 6.8 yrs; body mass index (BMI): 28.3 +/- 3.7 kg/m(2)] and 12 agesexBMI-matched healthy controls were assessed. REE (indirect calorimetry), body composition (bioelectrical impedance), the International Physical Activity Questionnaire (IPAQ), diet, Health Assessment Questionnaire (HAQ), disease activity [disease activity score 28 (DAS28), erythrocyte sedimentation rate (ESR), C-reactive protein] and serum TNF-alpha were measured before (Baseline) as well as 2 weeks (Time-1) and 12 weeks (Time-2) after initiation of anti-TNF-alpha treatment. Controls were only assessed at Baseline. Results. RA patients had significantly higher REE than controls at Baseline (1799.4 +/- 292.0 vs 1502.9 +/- 114.5 kcal/day, P = 0.002). Within the RA group, REE increased significantly between Time-1 and Time-2 (P = 0.001) but not between Baseline and Time-2. Sustained significant increases were observed in IPAQ (P = 0.001) and protein intake (P = 0.001). There were no significant changes in FFM or body fat. ESR (P = 0.002), DAS28 (P < 0.001), HAQ (P < 0.001) and TNF-alpha (P = 0.024) improved significantly. Physical activity (P = 0.001) and protein intake (P = 0.024) were significant between-subject factors for the elevation of REE. Conclusions. After 12 weeks of anti-TNF-alpha therapy, there were significant improvements in disease activity and physical function, as well as physical activity and protein intake, but no significant changes in REE or FFM. There is a need for longer-term studies in this field.
引用
收藏
页码:1824 / 1827
页数:4
相关论文
共 20 条
[1]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]
Bolanowski M, 2001, Med Sci Monit, V7, P1029
[3]
Selective carbohydrate or protein restriction: Effects on subsequent food intake and cravings [J].
Coelho, Jennifer S. ;
Polivy, Janet ;
Herman, C. Peter .
APPETITE, 2006, 47 (03) :352-360
[4]
International physical activity questionnaire:: 12-country reliability and validity [J].
Craig, CL ;
Marshall, AL ;
Sjöström, M ;
Bauman, AE ;
Booth, ML ;
Ainsworth, BE ;
Pratt, M ;
Ekelund, U ;
Yngve, A ;
Sallis, JF ;
Oja, P .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003, 35 (08) :1381-1395
[5]
Demura Shinichi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P93, DOI 10.2114/jpa.23.93
[6]
HEITMANN BL, 1994, INT J OBESITY, V18, P812
[7]
Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213
[8]
Tackling ischaemic heart disease in rheumatoid arthritis [J].
Kitas, GD ;
Erb, N .
RHEUMATOLOGY, 2003, 42 (05) :607-613
[9]
Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis [J].
Marcora, Samuele M. ;
Chester, Kathryn R. ;
Mittal, Gayatri ;
Lemmey, Andrew B. ;
Maddison, Peter J. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (06) :1463-1472
[10]
Marcora SM, 2005, J RHEUMATOL, V32, P1031